UK-based Concept Life Sciences, the growing life sciences, scientific laboratory and consultancy group, has bought Dundee’s CXR Biosciences.

CXR is a leading investigative toxicology business. Its in-house expertise assists international life sciences companies to resolve issues relating to the safety of compounds and with the selection of drug and chemical candidates. CXR, which has 33 staff, will retain its name and operate under the Concept Life Sciences’ Group umbrella. All staff, including the management team, are joining the Concept Life Sciences Group. CXR Biosciences’ CEO, Paul Smith, will continue to head up the business which will continue to be based in Dundee.

CXR was founded in 2001 as a spin-out from Dundee University with funding led by Archangels, the prominent Edinburgh-based business angel syndicate which has been at the forefront of early stage investing in Scotland for more than two decades.

Concept Life Sciences is a UK-based, international scientific laboratory and consultancy business working in the life, food and environmental sciences. Combining the resources, knowledge and experience of its companies, Concept Life Sciences provides a comprehensive platform of services to clients requiring innovative science based solutions. The business is supported by the leading European private equity group Equistone Partners Europe as part of its €1.5bn Fund IV.